Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Clinical trial NCT05242133 · COMPLETED

Trial details

NCT number: NCT05242133
Sponsor: Cinnagen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis (RRMS)

Start date: 2017-12-20
Primary completion: 2022-04-27
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.